Your session is about to expire
← Back to Search
E-Cigarettes for HIV/AIDS (ProjectSREC Trial)
N/A
Recruiting
Led By PATRICIA A CIOE, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
at least 18 years of age
smoke at least 5 cigarettes per day for longer than one year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
ProjectSREC Trial Summary
This trial will explore if switching to e-cigarettes can reduce health risks in HIV+ smokers who can't quit.
Who is the study for?
This trial is for HIV-positive adults who have been under care for the condition, are at least 18 years old, and have smoked more than 5 cigarettes daily for over a year. They must also show a certain level of carbon monoxide in their breath.Check my eligibility
What is being tested?
The study is testing if using standardized research electronic cigarettes (e-cigarettes) can help HIV-positive smokers reduce or quit smoking regular cigarettes, and what effects this switch has on heart and lung health.See study design
What are the potential side effects?
While not explicitly listed here, potential side effects may include throat irritation, coughing, dry mouth or increased nicotine dependence due to e-cigarette use.
ProjectSREC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
Select...
I have been smoking more than 5 cigarettes daily for over a year.
ProjectSREC Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in combustible cigarette use from baseline to 6 weeks
Secondary outcome measures
Change in Expired carbon monoxide (CO) level from baseline to 6 weeks
Change in Forced expiratory volume in 1 sec (FEV1) from baseline to 6 weeks
Change in serum biomarker levels from baseline to 6 weeks
+1 moreProjectSREC Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active conditionExperimental Treatment1 Intervention
Participants in the active condition will be provided with the Standardized Research Electronic Cigarette (SREC) and will be encouraged to use the SREC whenever they would normally smoke a cigarette.
Group II: Standard ConditionActive Control1 Intervention
Participants in this condition will be asked to continue to smoke their usual brand of cigarettes.
Find a Location
Who is running the clinical trial?
Brown UniversityLead Sponsor
456 Previous Clinical Trials
558,212 Total Patients Enrolled
PATRICIA A CIOE, PhDPrincipal InvestigatorBrown University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I have been smoking more than 5 cigarettes daily for over a year.I have HIV and have seen a doctor for it in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: Standard Condition
- Group 2: Active condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could you provide the aggregate number of participants in this investigation?
"Affirmative. Per the information housed on clinicaltrials.gov, this research project is currently recruiting volunteers and was initially posted on March 1st 2022. The study has been updated as recently April 21st 2023 and requires 72 participants from a single medical centre."
Answered by AI
Are new participants still being added to this research endeavor?
"According to clinicaltrials.gov, this medical investigation is actively recruiting subjects; the trial was uploaded on March 1st 2022 and its details were most recently revised on April 21st 2023."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger